The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population

• Autori principali: Naser Aslanabadi (Autore), Naser Safaie (Autore), Faezeh Shadfar (Autore), Mohammad Reza Taban-Sadeghi (Autore), Hossein Feizpour (Autore), Simin Ozar Mashayekhi (Autore), Hadi Hamishehkar (Autore), Naser Khezerlou Aghdam (Autore), Samaneh Dousti (Autore), Hossein Namdar (Autore), Taher Entezari-Maleki (Autore)
• Natura: Libro
• Pubblicazione: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objective: Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Reteplase is a fibrin-specific thrombolytic which is used in the treatment of AMI. There is a limited number of studies reporting the postmarketing adverse drug reactions (ADRs) induced by rete...